Mr. Milinazzo brings fifteen years of experience in interventional cardiology to bear on InspireMD's commercial strategy and operations as it launches a major new embolic protection stent technology platform, initially for patients undergoing emergency coronary intervention for potentially fatal heart attacks.
http://www.sys-con.com/node/2500455
http://www.sys-con.com/node/2500455
No comments:
Post a Comment